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The preparation of a reagent which can be used to attach biotin to proteins via a 
cleavable connector arm is described. The reagent, 3-(4-(N-biotinoyl-6-aminocaproyl- 
oxy)phenyl)propionic acid N-hydroxysuccinimide ester (BPE), can acylate amino 
groups of proteins and other compounds via reaction of the N-hydroxysuccinimide ester 
function. Compounds which have been covalently labeled with BPE can be selectively 
retrieved (at physiological pH values) from complex mixtures by adsorbing the target 
compounds on immobilized avidin. These compounds can be released from the avidin 
by cleavage of the phenyl ester linkage of the connector arm under conditions which 
don’t denature proteins. Insulin was labeled with BPE. The binding of the labeled 
insulin to immobilized avidin, and its subsequent release by treatment at room tem- 
perature with 1 M hydroxylamine at pH 7 was demonstrated. 
The highly specific and very strong bind- 
ing of biotin to avidin (KD - lo-l5 M; (7)) 
could provide us with a basis for the design 
of elegant protocols for the retrieval of 
compounds from cells and physiological 
fluids even when the compounds targeted 
for retrieval are present at very low con- 
centrations. For example, a polypeptide 
hormone that had been covalently labeled 
with biotin could be incubated with cells 
and later retrieved by adsorption on im- 
mobilized avidin for studies of hormone 
catabolism and for isolation of hormone- 
receptor complexes. Unfortunately, the 
direct application of this approach is usu- 
ally precluded by the very low rate con- 
stant for the dissociation of biotin from 
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avidin (ti,z -200 days; (7)), and the fact 
that all of the methods which are known 
to increase the rate of decomposition of 
the avidin:biotin complex lead to irrevers- 
ible protein denaturation. This difficulty 
has been overcome to some extent by the 
use of 2-iminobiotin (8, 10). Unlike biotin, 
2-iminobiotin interacts with avidin very 
poorly at low pH values. Thus, proteins 
labeled with 2-iminobiotin can be eluted 
from immobilized avidin at pH 4. There 
are two limitations associated with the use 
of 2-iminobiotin, however. One is that the 
pH must be above 9.5 for immobilized av- 
idin to exhibit significant adsorption of 2- 
iminobiotin-labeled proteins from dilute 
solutions (10). The other is that avidin 
binds 2-iminobiotin much less tightly than 
biotin. For example, the relative affinity 
of biotin and 2-iminobiotin for avidin is 
2.8 X 10’ at pH 9.5 and 3.5 X 104 at pH val- 
ues well above 12 where 2-iminobiotin 
(pK, 11.9) exists primarily in its basic 
form. These considerations suggest that 
a biotin label might be more useful than 
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a 24minobiotin label for specific retrieval solution or are present at very low con- 
of proteins and macromolecular complexes centrations (or both). In this work we de- 
of proteins which are unstable in alkaline scribe the preparation of a biotin deriva- 
tive (BPE)4 which can be used to link bio- 
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tin to polypeptides and other compounds 
via a cleavable connector arm. After the 
biotinoylated compound has been ad- 
sorbed on immobilized avidin under phys- 
iological conditions, it can be selectively 
released from the avidin by breaking the 
phenyl ester linkage in the connector arm. 
The cleavable phenyl ester linkage con- 
tained in BPE has an advantage over other 
cleavable linkages commonly used in 
crosslinking agents, in that it can be bro- 
ken under mild conditions which do not 
result in reduction of disulfide bonds or 
oxidation of glycosyl residues. 
MATERIALS AND METHODS 
N-Hydroxysuccinimide (NHS) obtained from Ald- 
rich Chemical Company was recrystallized from 
ethyl acetate. Dimethyl sulfoxide (Me#O) was dried 
over a molecular sieve and trifluoroacetic acid (Ald- 
rich Chemical Co.) was distilled. Triethylamine, di- 
methylformamide (DMF), isopropanol, and dioxane 
were distilled from phthalic anhydride, PzOs, CazS04, 
and LiAIHI, respectively. 
Ben& 8-(.&-h~droxgph.tm~l)pr@mate (I). 3-(4-Hy- 
droxyphenyl)propionic acid (HPPA), 50 g (0.3 mol) 
as obtained from Aldrich Chemical Company, was 
converted to the monopotassium salt by dissolving 
it in 300 ml of 1 N KOH, and removing the water 
under reduced pressure. The monopotassium salt of 
HPPA was dissolved in 400 ml of warm 95% ethanol 
in a round-bottom flask equipped with a reflux con- 
denser. The solution was heated to reflux, and benzyl 
bromide (32.5 ml, 0.273 mol) in 100 ml of ethanol was 
added over 1 h with stirring. The reaction mixture 
was heated under reflux for another 1.5 h, whereupon 
it was cooled, and the ethanol removed under reduced 
pressure. The resulting oil was suspended in 1.5 liters 
of HzO, neutralized to pH ‘7 with NaHCOa, and stirred 
for 0.5 h. The aqueous suspension was then extracted 
three times with ether, and the combined ether ex- 
tract, was back-extracted with 0.02 N sodium phos- 
phate buffer (pH 7). After the ether extract was dried 
over sodium sulfate, the ether was removed under 
reduced pressure, and the resulting oil was distilled 
under reduced pressure. The fraction which boiled 
at 170-174”C, 0.03 mm Hg, was collected to yield 46.8 
g (68%) of the desired product, an oil (d = 1.179) NMR 
(60 MHz CDCla + 1% TMS) 8 7.28 (5H, s, ArH), 6 6.92 
(4H, m, ArH), 6 5.09 (2H, s. ArCHzO), 6 2.72 (4H, m, 
CHz). The product exhibited a change in molar ab- 
sorptivity accompanying neutralization (with KOH) 
of the phenolic hydroxyl group which was within 3% 
of that seen for HPPA (AC% 2540 cm-’ M-’ in 20% 
ethanol-water). 
N- Benz&rxycnrbwql- 6- aminocaproic acid (II). 
Benzyl chloroformate (48 ml, 0.34 mol) was added 
slowly (over 1 h) to a vigorously stirred solution of 
6-aminocaproic acid (40 g, 0.31 mol) in 38 ml of 4 N 
NaOH which was cooled in an ice bath, and main- 
tained at pH 9.5-10.5 by addition of 4 N NaOH. After 
addition of the benzyl chloroformate, the solution 
was stirred for another 5 min, extracted three times 
’ Abbreviations used: B-insulin, the derivatives of 
insulin produced upon modification of insulin and 
tracer amounts of peaI]insulin with excess biotin N- 
hydroxysuccinimide ester; BPE, 3-(4-(biotinoyl-6- 
aminocaproyloxy)phenyl)propionic acid N-hydroxy- 
succinimide ester; BPE-insulin, the derivatives of in- 
sulin produced upon modification of insulin and 
tracer amounts of [12SI]insulin with excess BPE, BSA, 
bovine serum albumin; DMF, dimethylformamide; 
HPPA, 3-(+hydroxyphenyl)propionic acid; NHS, N- 
hydroxysuccinimide; NHS-CM-Sepharose, a deriva- 
tive of CM-Sepharose wherein the Sepharose-linked 
carboxylic acid groups have been converted to N-hy- 
droxysuccinimide esters; avidin-Sepharose, an im- 
mobilized avidin derivative obtained by reacting av- 
idin with NHS-CM-Sepharose; Me, methyl. 
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with ether, and acidified to pH 1 with concentrated 
HCl. The resulting precipitate was extracted into 
ethyl acetate. After drying the extract over Na$O,, 
the ethyl acetate was removed under reduced pres- 
sure. The solid residue was purified by three recrys- 
tallizations from ether:petroleum ether to yield 53.9 
g (68%) of the desired product, mp 55°C (lit. 54-55°C) 
(11) ir (KBr) amide 1732 cm-‘, NMR (60 MHz, CDCls 
+ 1% TMS) d 7.36 (5H, s, ArH), 6 5.08 (2H, s, ArCHs), 
6 3.15, 6 2.30, 6 1.42 (lOH, m, CHs). 
Benzyl g(~-(N-benzyll~-am~~~~l- 
oxy)phen~l)prwpi0nate (III). II (12 g, 45 mmol), I (12 
ml, 54 mmol), and POCls (2 ml, 22 mmol) were mixed 
in a round-bottom flask equipped with a reflux con- 
denser. The reaction mixture was heated in an oil 
bath at 100°C for 1.25 h, then cooled to room tem- 
perature, and extracted with ether by stirring the 
solution vigorously with three 300-ml portions of 
ether. The combined ether extract was back-ex- 
tracted three times with 0.02~ sodium phosphate 
buffer (pH 7). Ether was removed from the ether 
extract under reduced pressure. The residue was 
taken up in benzene and the benzene removed under 
reduced pressure. This process was repeated once so 
as to remove traces of water. The resulting residue, 
12g of crude III, was used without further purifi- 
cation. The phenyl ester content of crude III was 
determined as described below and was 59% of that 
expected for pure III. 
$-(4-(6-Aminocaproylp~yl)propionic acid hy- 
drobromide (IV). Crude III (2.49g containing 2.92 
mmol phenyl ester) and anisole (1 ml, 9.2 mmol) were 
mixed with 9 ml of trifluoroacetic acid, and HBr (g) 
was bubbled through the reaction mixture. After 1.75 
h, (which was found to be the optimum reaction 
time), the reaction mixture was poured with stirring 
into 300 ml of ether. The optimum reaction time for 
removal of the benzyl and benzyloxycarbonyl groups 
was indicated by the formation of a precipitate ap- 
proximately 5 min after 50 ~1 of the reaction mixture 
had been added to 1 ml of ether. Extended reaction 
times resulted in decomposition of the desired re- 
action product. After the reaction mixture had been 
stirred with the ether for 20 min, the resulting solid 
was collected, dissolved in ethanol, and precipitated 
with ether repeatedly to yield 0.46 g (44%) of IV mp 
160-161°C. The phenyl ester content (see below) of 
IV was 100% of that expected for pure IV, NMR (60 
Hz, DMSO - o$, + 1% TMS) b 1.52 (6H, m, CHs), 8 2.70 
(SH, m, CHs), 6 7.20 (4H, m, ArH), d 7.98 (3H, 
m, NH:). 
Biotin N-hydroxysuccinimide ester (V). This com- 
pound was synthesized using a procedure similar to 
that of May et al (9). A solution of biotin (4.01 g, 16.4 
mmol) and NHS (2.075g, 18.0 mmol) in 70 ml of 
Me#O was dried over molecular sieve (4 A) for 1.25 
h. The molecular sieve was removed, washed with 5 
ml of dry MesSO, and the wash was combined with 
the solution of biotin and NHS. N,N’-Dicyclohexyl- 
carbodiimide (3.4g, 16.5 mmol) in 40 ml of MezSO 
was added dropwise over 30 min to a stirred solution 
of the biotin and NHS. After 16 h, the N,N’-dicy- 
clohexylurea which had precipitated was removed by 
filtration. Me&30 was removed from the filtrate at 
70°C under reduced pressure, and the resulting prod- 
uct purified by two successive precipitations from 
1% acetic acid in DMF with ether. It was obtained 
in a 60% yield (3.35g), mp 208-21O”C, (lit. 208- 
210°C) (9). 
3 - (4 - (N - Biotinoyl - 6 - aminocaproyloxy)- 
phenyl)propionic acid (VI). A solution composed of 
8.6 mmol (1.2 ml) triethylamine in 20 ml of Mess0 
was added (during 5 min) to a stirred solution of V 
(1 g, 2.93 mmol) and IV (1.14 g, 3.19 mmol) in 50 ml 
of MqSO. The reaction mixture was stirred for an 
additional 13 min, whereupon it was poured onto 600 
g crushed ice which had been acidified with 4 ml of 
concentrated HCl. The resulting precipitate was 
rinsed with 0.01 N HCl, ice water, and 20 ml of 1% 
acetic acid in acetonitrile; and then dried under re- 
duced pressure at room temperature to yield 1.13 g 
(76%) of VI mp 199-200°C. The biotin content and 
phenyl ester content (see below) of this material were 
99 and 97%, respectively, of that expected for the 
pure compound. 
S - (4 - (N - Biotinoyl - 6 - aminocaproyloxy)- 
phenyl)prqpionio acid N-hydr~succinimide ester 
(VII). This compound was prepared from VI in a 
manner similar to that used to prepare the N-hy- 
droxysuccinimide ester of biotin. The product (mp 
177-179”(Z) was obtained in 62% yield (732 mg) from 
1 g (1.97 mmol) of VI. It exhibited phenyl ester, biotin, 
and N-hydroxysuccinimide ester contents (see below) 
which were 101, 99, and 100% of that expected for 
the pure VII. The product also chromatographed as 
a single component on HPLC on a 250 by 4.6 (i.d.)- 
mm Whatman Partisil-10 ODS C-18 column using 
1% acetic acid-2% DMF-97% acetonitrile (v/v/v) as 
eluent. Initial preparations of VII (prepared from 
impure VI) yielded a crude product from which pure 
VII could be obtained by this HPLC procedure. 
NHSCM-Sephurose. CM-Sepharose CL-6B (20 ml) 
obtained from Pharmacia was washed on a sintered 
glass funnel with 350 ml of 0.1 N HCl, 250 ml of water, 
and then with 60 ml of dioxane. The washed gel was 
activated with NHS according to a procedure similar 
to that of Cuatrecasas and Parikh (3). For activation, 
the washed gel was stirred with NHS (691 mg, 6 
mmol) and N,N’-dicyclohexylcarhodiimide (1.24 g, 6 
mmol) in 40 ml of dioxane for 70 min. After removal 
of the liquid phase, the gel was washed with 150 ml 
of dioxane, 200 ml methanol (to remove precipitated 
N,N’-dicyclohexylurea), and 100 ml dioxane. The 
resulting NHS-CM-Sepharose was stored under 
dioxane. 
Avidin Sepharose. NHS-CM-Sepharose (150 pl) was 
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washed with ice-cold 0.1 M phosphate buffer (pH 7.0) 
and added to 8.16 mg (124 nmol) of avidin (from 
Sigma) in 0.8 ml of ice-cold 0.1 M phosphate buffer 
(pH 7.0). The resulting suspension was stirred for 3 
h at room temperature. The gel was then washed four 
times with 1.0 ml of 0.1 M phosphate buffer (pH 7.0) 
and shaken with 1 ml of 1.0~ ethanolamine in 1.0 
M phosphate (pH 7.0) to decompose unreacted NHS 
ester. The resulting gel was washed six times with 
1.0 ml of 0.1 M phosphate buffer (pH 7.0) and the 
avidin-linked gel was diluted 1:lOO with gel that had 
been activated with NHS and then inactivated with 
ethanolamine without addition of avidin. The re- 
sulting gel mixture, avidin Sepharose, was suspended 
in sufficient 0.1 M phosphate buffer (pH 7.0) to pro- 
duce a suspension that contained 100 pl of gel/ml. 
Before use in studies of the binding of insulin to the 
gel, avidin Sepharose (100 ~1) was resuspended in 1.0 
ml of 1.0 mg/ml bovine serum albumin (BSA) in 0.1 
M phosphate buffer (pH 7.0) to minimize nonspecific 
binding of insulin. 
[‘%@ns&in Insulin (porcine, from Elanco) was io- 
dinated with carrier free Na’%I from Amersham by 
a modification of the method of Freychet et al (4). 
Insulin (106 pg, 17.4 nmol) in 0.12 ml of 0.05 M phos- 
phate buffer (pH 7.4) was mixed with 2 mCi Na? 
(0.91 nmol in 3.7 al) and 10 pl of 0.35 mM chloramine- 
T in 0.05~ phosphate buffer (pH 7.4). After 5 min 
the reaction was quenched by addition of 5 ~1 of 0.70 
mM sodium metabisulfite. The iodide and insulin were 
separated by gel exclusion chromatography on a 17 
X 0.7 (i.d.)-cm column of Sephadex G-25 Medium, 
which was eluted with 0.05~ sodium phosphate 
buffer (pH 7.4). 
[mIJIn&in derivative of VII (BPE-insulin). Insulin 
(1 mg, 0.17 pmol) in 2.0 ml of a solution containing 
30% acetonitrile-70% 0.2 M sodium phosphate buffer 
(pH 7.0) was stirred with a tracer amount (1.75 X 10’ 
cpm) of [12611insulin in 50 pl of 0.05 M phosphate buffer 
(pH 7.4) and 1 mg (1.7 pmol) VII. After 5.5 h at room 
temperature, the reaction was quenched by addition 
of 20 ~1 1 Y glycine. The volume of the reaction mix- 
ture was reduced to less than 1 ml under a stream 
of air. The precipitate which formed was removed by 
centrifugation and dissolved in 1 ml 0.02 M sodium 
phosphate buffer (pH 7.0). The resulting solution was 
subjected to gel exclusion chromatography on a 39 
x 1 (id.)-cm column of Sephadex G-25 medium and 
the insulin-containing fraction which appeared in the 
void volume was collected. 
[~Ijlneulin derivative of V (B-ins&in). This was 
prepared by a procedure similar to the one used to 
prepare BPE-insulin except that material which pre- 
cipitated during evaporation was not separated. In- 
stead, any precipitated material was dissolved by 
addition of sufficient 0.02 M sodium phosphate buffer 
(pH 7.0) to obtain a final volume of 2 ml. 
The phenyl ester content of compounds. This was 
determined from the time-dependent increase of ab- 
sorbance at 298 nm due the release of the phenoxide 
ion which accompanies solvolysis of the phenyl ester 
in basic ethanol. In a typical assay, 75 pl of a 10 mM 
(by weight) solution of ester in ethanol or DMF was 
added to 3 ml of ethanol which contained 5% by vol- 
ume of a solution composed of 25% tetrabutylam- 
monium hydroxide in methanol. The absorbance (288 
nm) of the solution was monitored continuously from 
the time of addition of the ester. The approach of the 
absorbance (A) to its final value (A,) was first order, 
and linear plots of In (A - A,) vs time were extrap- 
olated to the time of mixing to obtain the initial ab- 
sorbance (Ao) of the solution. (It should be noted that 
the contribution of the phenyl ester chromophore to 
A,, is negligible at 298 nm). The concentration of 
phenyl ester [PE] in the cuvette was calculated from 
the relationship 
[PE] = (Ar - A,,/2540, 
where 2540 cm-’ M-' is the molar absorptivity of the 
phenoxide ion of HPPA. The standard deviation for 
this analysis was less than 3%. 
The biotin wntent of compounds This was deter- 
mined by a modification of the dye displacement 
method of Green (5). In a typical analysis, a 10 mM 
solution of the biotin-containing compound in DMF 
was diluted to 5 pM with 0.05 M sodium phosphate, 
pH 6.5. A sample (0.82 ml) of this solution and 0.18 
ml of a solution containing 1.0 mg/ml avidin and 0.17 
mM 2-(4-hydroxyazobenzene)benzoic acid in water 
were mixed to yield a final volume of 1 ml. The ab- 
sorbance of this solution (at 500 nm) was determined 
and related to the biotin content of the sample using 
the linear dependence of the absorbance on the biotin 
content observed for samples containing known 
amounts of biotin. The standard deviation for this 
analysis was less than 3%. 
The N-H~drcrxgsuccinimide ester content of VII. 
This was determined from measurements of the ab- 
sorbance change (cm = 9038 cm-’ I+-‘) which accom- 
panied the release of NHS anion by imidazole. The 
absorbance (at 262 nm) of solutions composed of 50 
~1 of 10.2 mM (6.17 mg/ml) VII in DMF and 3 ml of 
solutions containing: 70% by volume 0.3 M sodium 
phosphate (pH = 7.1), 30% MesSO, and either 0.35 M 
imidasole or no imidaxole. The concentration of N- 
hydroxysuccinimide (lNHS]) released was calculated 
from the equation 
[NHS] = (A, - A,J/9038, 
where 9038 cm-’ K’ is the molar absorptivity of NHS 
under the assay conditions, AI is the observed ab- 
sorbance in the presence of 0.35 M imidasole and A0 
is the observed initial absorbance of VII in the ab- 
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sence of imidazole. The standard deviation for this 
analysis was less than 3%. 
General gperations used with avidin Sepharose. 
Gels were treated with solutions at room tempera- 
ture for the indicated times by shaking the mixtures 
on a Burrell wrist-action shaker or by stirring them 
on a magnetic stirrer. Both mixing procedures gave 
similar results. The reaction vessel was a 75 X 12 
(o.d.)-mm glass test tube, which could be used as a 
sample container in the gamma counter (Searle An- 
alytic Inc., Model 1130) for determinations of ra- 
dioactive material in the gel phase. Gels were washed 
by treating them for 1 min with the specified wash 
solution. Solutions were separated from gels by cen- 
trifugation on an International Clinical desk top cen- 
trifuge. Prior to determination of their radioactivity 
aliquots of the supernatant solutions were subjected 
to a second centrifugation in a Beckman microfuge 
to ensure removal of trace amounts of gel. 
Rem&m of insulin derivatives with awidin Sephar- 
ose. Avidin Sepharose (0.1 ml) was suspended in 0.5 
ml of 0.1 M sodium phosphate buffer, 0.1% BSA (pH 
7.0) and treated for 4 h with the indicated amounts 
of BPE-insulin or B-insulin. The unbound insulin 
derivative was removed by centrifugation and the gel 
was washed three times with 1 ml of 0.1 M phosphate 
buffer, 1 mg/ml BSA (pH 7.0) and once by treating 
the gel for 40 min with 1 ml of a buffer consisting 
of 0.1 M phosphate, 1 M NaCl, 1 mg/ml BSA (pH 7.0). 
The radioactivity of the washes was monitored as 
well as the radioactivity of the washed gel. The last 
wash contained less than 2% of the radioactivity of 
that which was present in the washed gel. 
Cleavage of phenyl ester linkages and release of gel- 
bound insulin This was accomplished by treating 0.1 
ml gel for 40 min with 1 ml of 1.0 M NHzOH, 1 mg/ 
ml BSA (pH 7.0). The hydroxylamine solution was 
prepared by addition of BSA to NHzOHHCl which 
had been neutralized with NaOH to pH 7.0, and ad- 
justed to 1 M NHzOH. After reaction with NHzOH 
the gel was washed three times with 1 ml of 0.1 M 
phosphate buffer, 1 mg/ml BSA (pH 7.0). The release 
of radioactive insulin derivative from the gel was 
monitored by determination of the radioactivity in 
the gel and liquid phases. 
The biotin binding capacity of avidin Sephmose. 
This was determined by treating a l.O-ml aliquot of 
avidin Sepharose suspension for 1 h with 50 pl of a 
solution containing a known concentration of biotin 
in water. The amount of biotin which bound to the 
gel was determined from the difference between the 
amount of biotin added and the amount of unbound 
biotin in the supernatant solution obtained after re- 
moval of the gel by centrifugation. The amount of 
biotin in the supernatant solution was determined 
in a manner similar to that described for the deter- 
mination of the biotin content of organic compounds. 
Biotin standards in the same buffer as the gel su- 
pernatant solution were used to calibrate the assay. 
RESULTS AND DISCUSSION 
Reaction of BPE with insulin resulted 
in covalent attachment of biotin to insulin 
as evidenced by the behavior of the resul- 
tant BPE-insulin toward avidin Sepharose 
(see below). The reaction of BPE with in- 
sulin should be analogous to that reported 
for the reaction of biotin N-hydroxysuc- 
cinimide ester (V) with insulin wherein N- 
hydroxysuccinimide is displaced from V 
by the amino groups of insulin with con- 
comitant formation of amide bonds (9). 
The biotin in the insulin derivative of V 
(B-insulin), however, is linked to the in- 
sulin via a noncleavable linkage, whereas 
in BPE-insulin the biotin is attached to 
the insulin via a cleavable connector arm. 
Since there are three amino groups in in- 
sulin, seven derivatives can result from 
the reaction of insulin with BPE or V.5 In 
the procedure used in this work to label 
insulin with BPE or V, a greater than 
ninefold molar excess of BPE or V was 
reacted with insulin for 5.5 h to ensure 
that essentially all of the insulin mole- 
cules would be covalently linked to at least 
one biotin group.6 Furthermore, the in- 
sulin was reacted in the presence of tracer 
amounts of [‘251]insulin to facilitate quan- 
tification of the binding of the resulting 
BPE-insulin or B-insulin to immobilized 
avidin (avidin-Sepharose). The titrations 
5 The seven insulin derivatives of V and BPE have 
been separated by HPLC. The preparation and phys- 
iological properties of these derivatives will be de- 
scribed elsewhere. 
6 The derivitized insulins used here are primarily 
trisubstituted with biotin. To obtain the other BPE- 
insulin derivatives, a mixture of the seven derivatives 
was prepared by reaction of a ninefold molar excess 
of BPE with 2 mg/ml insulin in a solution composed 
of equal volumes of acetonitrile and 0.2~ sodium 
phosphate buffer (pH 6.6 before mixing). After 45 
min the reaction mixture was quenched by addition 
of 0.1 volume of 2 M phosphoric acid. The seven BPE- 
insulin derivatives were isolated from each other and 
unreacted insulin by HPLC on a C-8 column using 
an acetonitrile-sodium phosphate (pH 3.1) gradient 
as eluent. 
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AMOUNT ADDED (nmol) 
FIG. 1. Titration of avidin Sepharose with BPE- 
insulin and B-insulin. The indicated amounts of BPE- 
insulin (0) and B-insulin (A) were stirred for 4 h with 
0.1 ml of avidin Sepharose in 0.1 M sodium phosphate 
buffer (pH 7) in a total volume of 1.03-1.3 ml. The 
squares indicate the amount of BPE-insulin remain- 
ing bound after treatment of the bound insulin (0) 
with 1 M hydroxylamine (pH 7) for 40 min at room 
temperature. Treatment of bound B-insulin (A) with 
hydroxylamine resulted in no change (~2%) in the 
amount of B-insulin bound to the avidin Sepharose. 
of avidin Sepharose depicted in Fig. 1 yield 
binding capacities of 11 nmol B-insulin 
and 8.9 nmmol BPE-insulin per milliliter 
of avidin Sepharose. Separate determi- 
nations of the capacity of the gel to bind 
free biotin indicated that the avidin Se- 
pharose could bind 31 nmol of biotin per 
milliliter of gel. The approximately three- 
fold lower binding capacity observed with 
BPE-insulin and B-insulin may well re- 
flect, in part, the ability of the polyvalent 
biotinoylated insulin derivatives to fill 
more than one biotin binding site. Limited 
access of the insulin derivatives to the bio- 
tin binding sites of the immobilized avidin 
could also account for the lower capacity 
of the gel to bind insulin. It should be 
noted that the avidin Sepharose used in 
this work resulted from a loo-fold dilution 
of immobilized avidin with inert gel (see 
under Materials and Methods). Thus, gels 
having as much as a loo-fold higher ca- 
pacity to bind biotin can be obtained sim- 
ply by diluting the immobilized avidin 
less. 
The initial slopes of 0.93 and 0.85 ob- 
served for the plots of the amount of B- 
insulin and BPE-insulin bound versus the 
amount of insulin derivative added (Fig. 
1) indicate that essentially all of the de- 
rivatized insulin was competent to bind to 
the avidin Sepharose. In the presence of 
excess avidin Sepharose, binding of bio- 
tinoylated insulin proceeded at a reason- 
able rate. For example, 0.17 nmol of BPE- 
insulin bound to 0.1 ml of avidin Sepharose 
(containing 0.89 nmol of sites for BPE-in- 
sulin) with a half-time of 8 min. This half- 
time for binding could be decreased by 
using gels which contained higher con- 
centrations of immobilized avidin. As 
the amount of biotinoylated insulin ap- 
proached the capacity of the avidin Se- 
pharose, the time required to ensure 
complete reaction (e.g., in the titrations 
depicted in Fig. 1) increased from 1 to 4 
h. The decreased rate of binding with in- 
creased degree of saturation may well re- 
flect the existence of a population of ster- 
ically hindered biotin binding sites which 
reacts more slowly with biotinoylated in- 
sulin. 
Previous studies from this laboratory 
(12, 13) demonstrated that a phenyl ester 
linkage such as the one in BPE-insulin is 
readily cleaved at 25°C by treatment with 
1 M hydroxylamine at pH 7.0. Figure 1 il- 
lustrates the greater than 85% release of 
BPE-insulin from avidin Sepharose that 
we obtained upon treatment of the bound 
BPE-insulin with 1 M hydroxylamine (pH 
7.0) for 40 min at room temperature. How- 
ever, well over 90% of the releasable BPE- 
insulin was released within 20 min. The 
failure to observe quantitative release of 
the BPE-insulin from the avidin Sephar- 
ose appears to be due to nonspecific inter- 
actions between the BPE-insulin and the 
Sepharose. Thus, the inert Sepharose de- 
rivative that was used to dilute the im- 
mobilized avidin (see under Materials and 
Methods) exhibited a binding capacity 
(after incubation of 0.1 ml gel with 2.7 
nmol BPE-insulin) which was 1.2 nmol/ml 
gel. Most of this nonspecifically bound in- 
sulin (0.9 nmol/ml gel) was not released 
by treatment with hydroxylamine. This 
amount of nonreleasable BPE-insulin ac- 
counts for most of the nonreleasable BPE- 
insulin (1.1 nmol/ml gel) which was ob- 
served when 0.1 ml avidin Sepharose was 
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incubated with 2.7 nmol of BPE-insulin 
and then treated with hydroxylamine (Fig. 
1). It should be noted that the nonspecific 
binding of proteins to the inert gel diluent 
can be minimized by the use of smaller 
volumes of gels which contain a higher 
fraction of the immobilized avidin. 
Several control experiments were per- 
formed to verify that binding of BPE-in- 
sulin to the avidin Sepharose was depen- 
dent on the biotin:avidin interaction and 
that the subsequent release of bound in- 
sulin from the gel was due to hydroxyl- 
amine-mediated cleavage of the phenyl 
ester-containing connector arm. Little 
binding (~5% of that expected for BPE- 
insulin) was observed when avidin Se- 
pharose was incubated with excess [lZI]- 
insulin which had not been treated with 
BPE. Avidin Sepharose that had been 
treated with hydroxylamine and then 
washed with buffer was indistinguishable 
from untreated avidin Sepharose with re- 
spect to its ability to bind biotin or BPE- 
insulin. Incubation of the avidin Sephar- 
ose with biotin prior to treatment of the 
gel with BPE-insulin resulted in binding 
which was at the level seen for the non- 
specific binding of BPE-insulin to the inert 
Sepharose diluent. Similarly, when avidin 
Sepharose was saturated with BPE-insu- 
lin and then treated with hydroxylamine 
to release the bound insulin from the gel, 
the resulting avidin Sepharose had a ca- 
pacity for additional BPE-insulin which 
was less than 10% of that observed for 
avidin Sepharose which had not been 
preincubated with BPE-insulin and hy- 
droxylamine. These results suggest that 
the pretreatment of the avidin Sepharose 
with BPE-insulin and hydroxylamine, like 
the pretreatment of avidin Sepharose with 
free biotin, saturated the insulin-accessi- 
ble biotin binding sites on the immobilized 
avidin, and thereby prevented subsequent 
binding of BPE-insulin. 
In the absence of added hydroxylamine, 
bound BPE-insulin was not released from 
avidin Sepharose by extensive washing 
with neutral buffers at either low or high 
concentrations of salt. The view that the 
release of insulin from avidin-bound BPE- 
insulin is dependent upon hydroxylamine- 
mediated cleavage of the phenyl ester link- 
age was further substantiated by studies 
with B-insulin wherein the biotin label is 
connected to insulin via a connector arm 
which should not be cleaved by the hy- 
droxylamine treatment. As shown in Fig. 
1, avidin Sepharose bound B-insulin and 
BPE-insulin similarly. However, less than 
2% of the bound B-insulin was released 
from the avidin Sepharose by the hydrox- 
ylamine treatment. 
The possibility that the hydroxylamine 
treatment described in this work could 
result in chemical modification of protein 
should be considered. Bornstein and Bal- 
bian (2) have shown that treatment of re- 
duced carboxymethylated ribonuclease for 
2 h at 45°C with 2 M hydroxylamine in 0.2 
M K&O3 at pH 9 resulted only in cleavage 
at an Asn-Gly bond and 5-10% cleavage 
at an Asn-Leu bond. It should be noted 
that this hydroxylamine-mediated cleav- 
age requires hydroxide ion-catalyzed at- 
tack of the nitrogen atom of the amide 
backbone on the /3-carboxamido group of 
the Asn to displace ammonia and form a 
cyclic imide. It is this imide intermediate 
which is then cleaved upon attack by the 
nucleophile hydroxylamine (1). Hydroxide 
ion-catalyzed formation of the imide in- 
termediate should be several hundred 
times slower at pH 7.0, 25°C than at pH 
9.0, 45°C. Thus, hydroxylamine-mediated 
peptide bond cleavage should not be sig- 
nificant under the conditions used to cleave 
the phenyl ester linkage. Naturally, one 
cannot a @ori exclude the possibility that 
some proteins might contain a bond which 
is reactive toward hydroxylamine. Should 
this become a concern, however, one could 
use a weaker nucleophile such as imidazole 
to cleave the phenyl ester linkage (12). 
The selective binding of BPE-insulin to 
avidin and its subseqent release suggests 
that BPE will enable us to exploit fully the 
high affinity of avidin for biotin in the 
design of protocols for selective retrieval 
of biotinoylated compounds from cells and 
physiological fluids. In the case of insulin, 
it is likely that some of the BPE-insulin 
derivatives will be useful for the isolation 
and characterization of the insulin recep- 
tor, since biotinoylated insulin derivatives 
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are competent to bind the insulin receptor 
of rat epididymal fat cells and induce in- 
sulin-like effects on metabolism ((9), and 
unpublished observations of this labora- 
tory). A possible limitation of the use of 
the biotin label (as well as any other 
probe) is that the label itself might modify 
the physiological properties of the poly- 
peptide so as to produce “artifactual” be- 
havior. Determination of the behavior of 
several different polypeptide derivatives 
should minimize this problem, however. 
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